Citation Impact
Citing Papers
Chromosome Abnormalities and Genetic Counseling
2011
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluation
2009
Acromegaly
2006 Standout
Gestational trophoblastic disease
2010 Standout
Variation in GH and IGF‐I assays limits the applicability of international consensus criteria to local practice
2007
Effects of prolactin on platelet activation and blood clotting
2013 StandoutNobel
Should macroprolactin be measured in all hyperprolactinaemic sera?
2009
Antipsychotic-Induced Hyperprolactinemia
2008
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Thyroid Cancer in Children
2007
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
A Nationwide Survey of Mortality in Acromegaly
2005
Undergoing prenatal screening for Down's syndrome: presentation of choice and information in Europe and Asia
2007
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Health Supervision for Children With Down Syndrome
2011 Standout
How Robust Are Laboratory Measures of Growth Hormone Status?
2005
Between ‘desperation’ and disability rights: a narrative analysis of complementary/alternative medicine use by parents for children with Down syndrome
2004
Macroprolactinemia in a Patient with Infertility and Hyperprolactinemia
2006
The routine and the traumatic in prenatal genetic diagnosis: does clinical information inform patient decision-making?
2004
Differences in Recognition of the 1st WHO International Reference Reagents for hCG-Related Isoforms by Diagnostic Immunoassays for Human Chorionic Gonadotropin
2009
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Clinical Practice: Quality Requirements1
2008
Serum prolactin and macroprolactin in heart failure: no relation to established laboratory or clinical parameters
2010
Decision aids for people facing health treatment or screening decisions
2017 Standout
Analytical error and interference in immunoassay: minimizing risk
2011
Basal and Glucose-Suppressed GH Levels Less Than 1 μg/L in Newly Diagnosed Acromegaly
2003
Guidelines for the management of thyroid cancer
2014 Standout
Serum Total Prolactin and Monomeric Prolactin Reference Intervals Determined by Precipitation with Polyethylene Glycol: Evaluation and Validation on Common ImmunoAssay Platforms
2008
Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin-like Growth Factor Assays
2011
Works of Andy Ellis being referenced
External quality assessment of immunoassays of peptide hormones and tumour markers: principles and practice.
1991
Descriptive information about Down syndrome: a content analysis of serum screening leaflets
2001
Pegvisomant interference in GH assays results in underestimation of GH levels
2007
Serum Growth Hormone Measurements in Clinical Practice: An Audit of Performance from the UK National External Quality Assessment Scheme
1999
Quality of written information used in Down syndrome screening
2001
Standardization of FSH, LH and hCG—Current position and future prospects
2006
Spuriously elevated plasma calcitonin in a patient with a thyroid nodule not associated with medullary thyroid carcinoma
1999
Macroprolactin; high molecular mass forms of circulating prolactin
2005